Full patent in 2019 (University of Nevada Reno), priority 6/21/2018 (wipo: Wo2019246398);

IP :“Disease Modifying Methods For Treating Neurodegenerative Diseases Using Nootropic Agents”

US patent: US 2021/0220322

Response to the US Patent Office filed on October of 2022- Granted, March of 2023

Invetors : DAGDA, Ruben K & DAGDA, Raul Y.